Evaluation of human neutrophil elastase inhibitory effect of iridoid glycosides from Hedyotis diffusa

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 2, 2010, Pages 513-515

  Xu, Guang Hua ^a   Kim, Young Hee ^a   Chi, Seung Wook ^a   Choo, Soo Jin ^a   Ryoo, In Ja ^a   Ahn, Jong Seog ^a   Yoo, Ick Dong ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Hedyotis diffusa; Human neutrophil elastase; Iridoid glycosides

Indexed keywords

6 O 4 COUMAROYL SCANDOSIDE METHYL ESTER; 6 O 4 FERULOYL SCANDOSIDE METHYL ESTER; 6 O 4 METHOXYCINNAMOYL SCANDOSIDE METHYL ESTER; EPIGALLOCATECHIN GALLATE; HEDYOTIS DIFFUSA EXTRACT; IRIDOID; LEUKOCYTE ELASTASE; LEUKOCYTE ELASTASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG BINDING; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HYDROGEN BOND; IC 50; MOLECULAR DOCKING; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

BINDING SITES; COMPUTER SIMULATION; HEDYOTIS; HUMANS; IRIDOIDS; LEUKOCYTE ELASTASE; PLANT EXTRACTS; PROTEASE INHIBITORS;

HEDYOTIS DIFFUSA;

EID: 72249085972     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.11.109     Document Type: Article

References (25)

1. El-Domyati M., Attia S., Saleh F., Brown D., Birk D.E., Gasparro F., Ahmad H., and Uitto J. Exp. Dermatol. 11 (2002) 398
2. Baumann L. J. Pathol. 211 (2007) 241
3. Wiltried M., Klaus N., and Lin Z.F. Arch. Dermatol. Res. 270 (1994) 397
4. Wiedow O., Schroder J.M., Gregory H., Young J.A., and Christophers E. J. Biol. Chem. 265 (1990) 14791
5. Steinbrecher T., Hrenn A., Dormann K.L., Merfort I., and Labahn A. Bioorg. Med. Chem. 16 (2008) 2385
6. Antonicelli F., Bellon G., Debelle L., and Hornebeck W. Curr. Top. Dev. Biol. 79 (2007) 99
7. Lee K.K., Kim J.H., Cho J.J., and Choi J.D. Int. J. Cosmet. Sci. 21 (1999) 71
8. Kim S.H., Ahn B.Z., and Ryu S.Y. Phytother. Res. 12 (1998) 553
9. Permana D., Lajis N.H., Abas F., Othman A.G., Ahmad R., Kitajima M., Takayama H., and Aimi N. Nat. Prod. Sci. 9 (2003) 7
10. Lin C.C., Ng L.T., Yang J.J., and Hsu Y.F. Am. J. Chin. Med. 30 (2002) 225
11. Kim Y., Park E.J., Kim J., Kim Y., Kim S.R., and Kim Y.Y. J. Nat. Prod. 64 (2001) 75
12. Kim D.H., Lee H.J., Oh Y.J., Kim M.J., Kim S.H., Jeong T.S., and Baek N.I. Arch. Pharm. Res. 28 (2005) 1156
13. Lu C.M., Yang J.J., Wang P.Y., and Lin C.C. Planta Med. 66 (2000) 374
14. Huang W.H., Yu S.H., Li Y.B., and Jiang J.Q. J. Asian Nat. Prod. Res. 10 (2008) 887
15. Kim Y.H. Kor. J. Medicinal Crop Sci. 3 (1995) 91
16. R, 33 min, 40 mg), respectively.
17. Rathore A., Juneja R.K., and Tandon J.S. Phytochemistry 28 (1989) 1913
18. Damtoft S., Jensen S.R., and Nielsen B.J. Phytochemistry 20 (1981) 2717
19. Miyagoshi M., Amagaya S., and Ogihara Y. Planta Med. 53 (1987) 462
20. -.
21. Wu H., Tao X., Chen Q., and Lao X. J. Nat. Prod. 54 (1991) 254
22. Liang Z.T., Jiang Z.H., Leung K.S., and Zhao Z.Z. Chem. Pharm. Bull. 54 (2006) 1131
23. HNE inhibitory activity was evaluated according to previously described procedure (Benedek, B.; Kopp, B.; Melzig, M. F. J. Ethnopharmacol. 2007, 113, 312.). Briefly, 125 μL of substrate solution [1.4 mM N-methoxysuccinyl-ala-ala-pro-val-p-nitroanilide, in Tris-HCl buffer (pH 7.5)], 60 μL of test solution [stock solutions of the test compounds were dissolved in 500 μL DMSO and diluted with Tris-HCl buffer to give the final sample concentrations] and 390 μL of Tris-HCl buffer were mixed and vortexed. After addition of 25 μL enzyme solution (approx. 0.18 U elastase from human neutrophils, EC 3.4.21.37, from Serva, Heidelberg, Germany) the samples were incubated for 1 h at 37 °C. After the reaction was stopped by addition of 500 μL soybean trypsin inhibitor [Sigma, Germany; 0.2 mg/mL Tris-HCl buffer (pH 7.5)], absorbance was immediately measured at 405 nm. Epigallocatechin gallate (EGCG) (Sigma, Germany) was used as a positive control.
24. To build a structural model for the HNE in complex with compound 1, compound 1 was docked into the HNE (PDB code: 1HNE) by cdocker program in the software Discovery Studio 2.1 (Accelrys). Ten initial random conformations were taken and 10 initial poses were chosen for final refinement. CHARMm forcefield was employed for molecular dynamics and dynamics steps and target temperature were set to be 1000 and 1000 K, respectively. Figures were drawn by using the software Discovery Studio 2.1.
25. Navia M.A., McKeever B.M., Springer J.P., Lin T.Y., Williams H.R., Fluder E.M., Dorn C.P., and Hoogsteen K. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 7